Related Experiment Video
Updated: Aug 30, 2026

Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
Early events in ovarian oncogenesis
1Ovarian Cancer Program, Division of Medical Science, Fox Chase Cancer Center, Philadelphia, PA, USA. DI_Cvetkovic@fccc.edu
Abstract:
Ovarian cancer represents the most lethal of the gynecological neoplasms. The molecular and genetic events associated with early ovarian oncogenesis are still largely unknown, thus contributing to the lack of reliable biomarkers for disease detection. Since the majority of ovarian tumors are diagnosed at an advanced stage, the availability of early ovarian cancer tissue samples for molecular analyses is very limited. In this review, problems encountered in the study of early ovarian cancer are presented, along with the controversies concerning precursor lesions and stepwise progression towards ovarian malignancy. Experimental modeling in the development of ovarian cancer is also described, as well as genetic and epigenetic alterations associated with early ovarian cancer. Lastly, examples of technological advances in the study of early ovarian cancer are discussed. Hopefully, the increasing knowledge about molecular and genetic events involved in the early stages of ovarian tumorigenesis will provide the basis for management of ovarian cancer in the future.
Insights
Early ovarian cancer research is hampered by limited tissue samples and unknown molecular events, hindering biomarker development. Understanding early tumorigenesis is crucial for future ovarian cancer management.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Ovarian cancer is a leading cause of gynecologic cancer death.
- Early molecular and genetic events in ovarian oncogenesis remain largely unknown.
- Limited availability of early-stage ovarian cancer tissues impedes research.
Purpose of the Study:
- To review challenges in studying early ovarian cancer.
- To discuss precursor lesions and stepwise progression.
- To highlight genetic/epigenetic alterations and technological advances.
Main Methods:
- Literature review of early ovarian cancer research.
- Discussion of experimental modeling approaches.
- Analysis of genetic and epigenetic alterations.
Main Results:
- Significant challenges exist in obtaining and analyzing early ovarian cancer samples.
- Controversies surround precursor lesions and tumor progression pathways.
- Various genetic and epigenetic alterations are implicated in early stages.
Conclusions:
- Knowledge gaps in early ovarian cancer molecular events persist.
- Technological advancements offer new avenues for research.
- Understanding early tumorigenesis is key to improving future ovarian cancer detection and treatment.
Related Concept Videos
Oogenesis
Oogenesis
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Folliculogenesis
Ovarian Cycle
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...

